Papachristou Maria, Priftakis Dimitrios, Xanthopoulos Stavros, Datseris Ioannis, Bouziotis Penelope
Nuclear Medicine and PET/CT Department, General Hospital of Athens "Evaggelismos" Athens, Greece.
Institute of Nuclear Medicine, University College London Hospital London, United Kingdom.
Am J Nucl Med Mol Imaging. 2022 Jun 15;12(3):91-98. eCollection 2022.
When injected intravenously, [Tc]Tc-phytate forms particles in the nanometer range. This size can favor its extravasation into tumor and inflammation through pores of the vasculature. The aim of this work is the evaluation of the use of [Tc]Tc-phytate to assess sterile inflammation in mouse models. Biodistribution studies of [Tc]Tc-phytate were performed in two groups of male Swiss Albino mice. Sterile inflammation was induced after intramuscular injection of turpentine in the first group (chemically induced sterile inflammation model) and after implantation of sterile metal bolts in the second group (foreign-body induced sterile inflammation model). [Tc]Tc-phytate was intravenously injected after the development of inflammation in both groups and biodistribution of the radiolabelled complex followed at different time-points. Biodistribution was expressed as percent injected dose per gram (%ID/g). Target-to-background ratios were also recorded. For the chemically induced sterile inflammation model, biodistribution evaluation measurements revealed a pronounced uptake in the inflamed muscle when compared to uptake in the control/non-inflamed muscle. Moreover, as expected, there is a high uptake in the liver and spleen. For the foreign-body induced sterile inflammation model, a significantly higher uptake was observed in the inflamed muscle post [Tc]Tc-phytate injection, both for the 24 hours post-bolt implantation and for the 7 days post-bolt implantation groups. The nanoparticle properties of [Tc]Tc-phytate are potentially useful in the imaging of different types of sterile inflammation with translational potential clinical SPECT (single photon emission computed tomography) imaging applications in humans.
静脉注射时,[锝]锝-植酸盐会形成纳米级的颗粒。这种尺寸有利于其通过脉管系统的孔隙渗入肿瘤和炎症部位。本研究的目的是评估[锝]锝-植酸盐在小鼠模型中评估无菌性炎症的应用。在两组雄性瑞士白化小鼠中进行了[锝]锝-植酸盐的生物分布研究。在第一组中,通过肌肉注射松节油诱导无菌性炎症(化学诱导无菌性炎症模型),在第二组中,通过植入无菌金属螺栓诱导无菌性炎症(异物诱导无菌性炎症模型)。在两组炎症形成后静脉注射[锝]锝-植酸盐,并在不同时间点跟踪放射性标记复合物的生物分布。生物分布以每克注射剂量的百分比(%ID/g)表示。还记录了靶本底比值。对于化学诱导无菌性炎症模型,生物分布评估测量显示,与对照/非炎症肌肉中的摄取相比,炎症肌肉中有明显的摄取。此外,正如预期的那样,肝脏和脾脏中有高摄取。对于异物诱导无菌性炎症模型,在[锝]锝-植酸盐注射后的炎症肌肉中观察到显著更高的摄取,无论是在植入螺栓后24小时组还是植入螺栓后7天组。[锝]锝-植酸盐的纳米颗粒特性在不同类型无菌性炎症的成像中可能有用,具有在人类中进行潜在临床单光子发射计算机断层扫描(SPECT)成像应用的转化潜力。